Mini Review
Volume 7 Issue 6 - 2020
Management of Hypertension in COVID-19 Era
Mostafa Qaid Al Shamiri*
Associate Professor of Cardiac Science, Cardiac Science Department, Faculty of Medicine King Saud University, Riyadh, Kingdome of Saudi Arabia
*Corresponding Author: Mostafa Qaid Al Shamiri, Associate Professor of Cardiac Science, Cardiac Science Department, Faculty of Medicine King Saud University, Riyadh, Kingdome of Saudi Arabia.
Received: May 07, 2020; Published: May 18, 2020




Abstract

Pandemic COVID-19 started as pandemic in china and it spreads fast to involve all countries in different part of the world. Early studies found that hypertensive patients affected by the virus had more hospitalizations and mortality. Some data of non-evidence based claimed that ACEi and ARBS in hypertension who infected by the virus may contribute to worse outcome.

Elderly hypertensive may over express ACE2 with or without COVID-19 infections. Over expression of ACE2 did not proven to be harmful for hypertensive patients regardless of elevated blood pressure (BP). Patients with medication should continue using them including ACEi or ARBS, in addition to lifestyle modifications to keep home BP < 135/85 MMHG.

Keywords: Hypertension; COVID-19; ACEi; ARBS; ACE2 Guidelines

References

  1. "Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg”. The Journal of the American Medical Association 7 (1970):1143-1152.
  2. Chow CK., et al. “Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries”. The Journal of the American Medical Association 310 (2013): 959-968.
  3. Wolf-Maier., et al. “Hypertension Treatment and Control in Five European Countries, Canada, and the United States”. Hypertension 43 (2004): 10-17.
  4. Vasan RS., et al. “Residual Lifetime Risk for Developing Hypertension in Middle-aged Women and Men: The Framingham Heart Study”. The Journal of the American Medical Association 8 (2002):1003-1010.
  5. Bryan Williams., et al. “ESC/ESH Guidelines for the management of arterial hypertension”. European Heart Journal 39 (2018): 3021-3104.
  6. Goyal P., et al. “Clinical Characteristics of Covid-19 in New York City [published online ahead of print”. The New England Journal of Medicine (2020).
  7. Shikha Garg., et al. “Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 - COVID-NET (2020).
  8. Sommerstein R and Grani C. “Rapid response: regarding: preventing a covid-19 pandemic: ACE inhibitors as a potential risk factor for fatal Covid-19”. British Medical Journal (2020).
  9. Lu J., et al. “Prevalence, awareness, treatment, and control of hypertension in China: data from 1.7 million adults in a population-based screening study (China PEACE Million Persons Project)”. Lancet 390 (2017): 2549-2558.
  10. Fernández‐Atucha A., et al. “Sex differences in the aging pattern of renin‐angiotensin system serum peptidases”. Biology of Sex Differences 8 (2017): 5.
  11. Walters TE., et al. “Angiotensin converting enzyme 2 activity and human atrial fibrillation: increased plasma angiotensin converting enzyme 2 activity is associated with atrial fibrillation and more advanced left atrial structural remodeling”. Europace 19 (2017): 1280-1287.
  12. Chappel MC and Ferrario CM. “ACE and ACE2: their role to balance the expression of angiotensin II and angiotensin‐(1‐7)”. Kidney International 70 (2006): 8-10.
  13. Kuba K., et al. “A crucial role of angiotensin :converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury”. Nature Medicine 11 (2005): 875-879.
  14. Gurwitz D. “Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics”. Drug Dev Review 27 (2020): 1-4.
  15. Mandeep R Mehra., et al. “Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19” (2020).
  16. Peng Zhang., et al. “Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients with Hypertension Hospitalized With COVID-19 (2020): 17.
  17. Giuseppe Mancia., et al. “Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19 (2020).
  18. Gabriela M Kuster., et al. “SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19?” European Heart Journal (2020): 1-3.
  19. Terry McCormack., et al. “The 2018 ESC/ESH hypertension guideline and the 2019 NICE hypertension guideline, how and why they differ”. European Heart Journal 40-42.7 (2019): 3456-3458.
Citation: Mostafa Qaid Al Shamiri. “Management of Hypertension in COVID-19 Era”. EC Cardiology 7.6 (2020): 25–28.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


May Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the May issue of respective journals and can be viewed in the current issue pages.

Submission Deadline for July Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the June issue of respective journals. Submissions are accepted on/before June 11, 2020.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk